Brevan Howard Capital Management LP Ionis Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 21,366 shares of IONS stock, worth $669,824. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,366
Previous 28,479
24.98%
Holding current value
$669,824
Previous $1.14 Million
34.56%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$516 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$444 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$359 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$324 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$272 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.45B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...